Siegfried: German Kartellamt greenlights acquisition of three BASF sites
As announced earlier, Siegfried Group has signed an agreement with BASF of Germany concerning the acquisition of significant segments of that company’s pharmaceutical supply business and connected chemical-pharmaceutical production units in France, Germany and Switzerland. The German antitrust authorities (Bundeskartellamt) have now disclosed that it has no reservations concerning the acquisition of three BASF sites by the Siegfried Group, an important precondition for implementation of the agreements. Siegfried, therefore, expects the agreement to be finalized at the beginning of the fourth quarter.
Other news from the department business & finance

Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.